CHI3L1 and lung cancer: Lung cancer cells were pretreated with the AKT inhibitor 30 min before their treatment with ebractenoid F; then, the expression levels of proteins related to cell growth and apoptosis and CHI3L1 were analyzed (Figure 8A,B).